Alfacell's ONCONASE Shows Promise As Radiation Sensitizer For Lung Cancer Treatment

LOS ANGELES -- Alfacell Corporation (Nasdaq: ACEL) today announced that Dr. Intae Lee with the University of Pennsylvania has reported that Alfacell's ONCONASE could be a promising radiation sensitizer for lung cancer treatment. Dr. Lee presented the pre- clinical in vivo data at the American Society for Therapeutic Radiology and Oncology (ASTROs) 49th Annual Meeting being held Oct. 28-Nov. 1 in Los Angeles. During his presentation, Dr. Lee provided pre-clinical evidence that ONCONASE significantly increased the radiation-induced tumor growth delay of lung tumors in vivo without increases in skin reaction compared to radiation alone. Additionally, Dr. Lee and his team of researchers identified non- invasive imaging biom...